{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:47:05Z","timestamp":1781459225681,"version":"3.54.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2016\/000675"],"award-info":[{"award-number":["EMR\/2016\/000675"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022370","name":"Global Challenges Research Fund","doi-asserted-by":"publisher","award":["GCRF 105123-11"],"award-info":[{"award-number":["GCRF 105123-11"]}],"id":[{"id":"10.13039\/501100022370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Antibiot."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>In response to continued public health emergency of antimicrobial resistance (AMR), a significant key strategy is the discovery of novel mycobacterial efflux-pump inhibitors (EPIs) as potential adjuvants in combination drug therapy. Interest in identifying new chemotypes which could potentially synergize with the existing antibiotics and can be deployed as part of a combination therapy. This strategy could delay the emergence of resistance to existing antibiotics and increase their efficacy against resistant strains of mycobacterial species. In recent decades, notable approaches have been accounted for EPI development and have resulted in the discovery of several EPIs including SQ109 and AU1235. In context, to accelerate newer EPIs with novel mode of action here we have discussed mycobactin analogues and highlighted <jats:italic>in silico<\/jats:italic> binding orientation with siderophore efflux-pump proteins MmpL4\/5.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>3-(2-hydroxyphenyl)-5-(aryl)-pyrazoline series was investigated for whole-cell efflux-pump inhibitory activity against <jats:italic>Mycobacterium smegmatis<\/jats:italic> and <jats:italic>Mycobacterium abscessus.<\/jats:italic> Machine learning and molecular dynamics were performed to construct a MmpL4\/5 complex embedded in a lipid bilayer to identify the putative binding site and to predict ligand-protein binding energetics. Furthermore, the identified HIT compound was investigated in synergistic assay with bedaquiline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compound <jats:bold>Il<\/jats:bold>, 2-(5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, was identified as the most potent efflux pump inhibitor against <jats:italic>M. smegmatis<\/jats:italic> in whole-cell efflux-pump investigation. Followed HIT <jats:bold>Il<\/jats:bold> employed against <jats:italic>M. abscessus<\/jats:italic> for efflux-pump inhibition investigations and notable whole-cell efflux-pump inhibitory profile has been observed. The theoretical investigations predicted compound <jats:bold>Il<\/jats:bold> to be selective towards MmpL4, with significant hydrogen bonding and \u03c0-\u03c0 stacking interactions effectively blocking a critical Asp-Tyr dyad interaction network necessary for proton translocation. Compound <jats:bold>Il<\/jats:bold> with bedaquiline highlighted an additive profile against the <jats:italic>M. abscessus<\/jats:italic> pathogen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MD simulations and whole-cell assays are indicating potential development of compound <jats:bold>Il<\/jats:bold> as an adjunct to the existing therapeutic regimen against mycobacterial infections.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frabi.2024.1362516","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:51:08Z","timestamp":1715143868000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays"],"prefix":"10.3389","volume":"3","author":[{"given":"Mousumi","family":"Shyam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib","family":"Bhakta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesan","family":"Jayaprakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/mmi.13283","article-title":"Insights into the smooth-to-rough transitioning in Mycobacterium bolletii unravels a functional Tyr residue conserved in all mycobacterial MmpL family members","volume":"99","author":"Bernut","year":"2016","journal-title":"Mol. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1042\/BST20190950","article-title":"Targeting MmpL3 for anti-tuberculosis drug development","volume":"48","author":"Bolla","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"B3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3390\/pathogens11090953","article-title":"Mycobacterium abscessus mutants with a compromised functional link between the type VII ESX-3 system and an iron uptake mechanism reliant on an unusual mycobactin siderophore","volume":"11","author":"Bythrow","year":"2022","journal-title":"Pathogens"},{"key":"B4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/mmi.2010.78.issue-4","article-title":"MmpS4 promotes glycopeptidolipids biosynthesis and export in Mycobacterium smegmatis","volume":"78","author":"Deshayes","year":"2010","journal-title":"Mol. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1021\/acs.jctc.1c01217","article-title":"Lipid21: complex lipid membrane simulations with AMBER","volume":"18","author":"Dickson","year":"2022","journal-title":"J. Chem. Theory Comput."},{"key":"B6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","article-title":"Multidrug efflux pumps: structure, function and regulation","volume":"16","author":"Du","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41598-023-29817-0","article-title":"AcrAB efflux pump impacts on the survival of adherent-invasive Escherichia coli strain LF82 inside macrophages","volume":"13","author":"Fanelli","year":"2023","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00850-19","article-title":"Two accessory proteins govern mmpL3 mycolic acid transport in mycobacteria","volume":"10","author":"Fay","year":"2019","journal-title":"mBio"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.3390\/molecules27206948","article-title":"Why matter matters: fast-tracking mycobacterium abscessus drug discovery","volume":"27","author":"Ganapathy","year":"2022","journal-title":"Molecules"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3390\/molecules27206948","article-title":"Kobophenol A inhibits binding of host ACE2 receptor with spike RBD domain of SARS-CoV-2, a lead compound for blocking COVID-19","volume":"12","author":"Gangadevi","year":"2021","journal-title":"J.  Phys. Chem. Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3390\/molecules27206948","article-title":"Discovery of 3-chlorobenzyl-linked 1, 9-diazaspiro [5.5] undecane derivatives, a lead for dengue virus type 2 infection","volume":"46","author":"Gangireddy","year":"2022","journal-title":"New J. Chem."},{"key":"B12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4939-1465-4_12","article-title":"\u201cAccelerated molecular dynamics and protein conformational change: A theoretical and practical guide using a membrane embedded model neurotransmitter transporter,\u201d","volume-title":"Molecular Modeling of Proteins","author":"Gedeon","year":"2015"},{"key":"B13","doi-asserted-by":"publisher","first-page":"12293","DOI":"10.1021\/acs.jpcb.6b09535","article-title":"Modeling membrane protein\u2013ligand binding interactions: the human purinergic platelet receptor","volume":"120","author":"Greene","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"B14","doi-asserted-by":"publisher","first-page":"11919","DOI":"10.1063\/1.1755656","article-title":"Accelerated molecular dynamics: A promising and efficient simulation method for biomolecules","volume":"120","author":"Hamelberg","year":"2004","journal-title":"J. Chem. Phys."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1021\/acs.jctc.7b00581","article-title":"Consensus conformations of dinucleoside monophosphates described with well-converged molecular dynamics simulations","volume":"14","author":"Hayatshahi","year":"2018","journal-title":"J. Chem. Theory Comput."},{"key":"B16","doi-asserted-by":"publisher","first-page":"114502","DOI":"10.1063\/5.0019056","article-title":"A fast and high-quality charge model for the next generation general AMBER force field","volume":"153","author":"He","year":"2020","journal-title":"J. Chem. Phys."},{"key":"B17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1021\/acsinfecdis.9b00373","article-title":"Large-scale chemical-genetic strategy enables the design of antimicrobial combination chemotherapy in mycobacteria","volume":"6","author":"Johnson","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"B20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tim.2021.05.001","article-title":"Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance","volume":"30","author":"Laws","year":"2022","journal-title":"Trends Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0022-2836(67)90353-1","article-title":"A fluorescent complex between ethidium bromide and nucleic acids: Physical\u2014Chemical characterization","volume":"27","author":"Lepecq","year":"1967","journal-title":"J. Mol. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0119013","article-title":"Efflux pump gene expression in multidrug-resistant mycobacterium tuberculosis clinical isolates","volume":"10","author":"Li","year":"2015","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.bpj.2023.03.018","article-title":"Insights into substrate transport and water permeation in the mycobacterial transporter MmpL3","volume":"122","author":"Li","year":"2023","journal-title":"Biophys. J."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4103\/2229-516X.112228","article-title":"Bedaquiline: First FDA-approved tuberculosis drug in 40 years","volume":"3","author":"Mahajan","year":"2013","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jgar.2022.10.015","article-title":"Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps","volume":"31","author":"Mudde","year":"2022","journal-title":"J. Global Antimicrobial Resistance"},{"key":"B30","article-title":"Antimicrobial resistance: tackling a crisis for the health and wealth of nations","volume-title":"Review on antimicrobial resistance","author":"O\u2019Neill","year":"2014"},{"key":"B31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/jac\/dkv316","article-title":"Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy","volume":"71","author":"Pule","year":"2015","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/14787210.2020.1760845","article-title":"Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs","volume":"18","author":"Rodrigues","year":"2020","journal-title":"Expert Rev. Anti-infective Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1021\/acs.jcim.9b00269","article-title":"PACKMOL-memgen: A simple-to-use, generalized workflow for membrane-protein\u2013lipid-bilayer system building","volume":"59","author":"Schott-Verdugo","year":"2019","journal-title":"J. Chem. Inf. Modeling"},{"key":"B35","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1080\/17460441.2022.2077328","article-title":"Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: where we stand","volume":"17","author":"Shyam","year":"2022","journal-title":"Expert Opin. Drug Discovery"},{"key":"B36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1021\/acs.jmedchem.0c01176","article-title":"The mycobactin biosynthesis pathway: A prospective therapeutic target in the battle against tuberculosis","volume":"64","author":"Shyam","year":"2021","journal-title":"J. Medicinal Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1021\/acs.jmedchem.1c01349","article-title":"Mycobactin analogues with excellent pharmacokinetic profile demonstrate potent antitubercular specific activity and exceptional efflux pump inhibition","volume":"65","author":"Shyam","year":"2022","journal-title":"J. Medicinal Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1021\/acs.biochem.2c00586","article-title":"Shorter alkanesulfonate carbon chains destabilize the active site architecture of SsuD for desulfonation","volume":"62","author":"Somai","year":"2023","journal-title":"Biochemistry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.03.011","article-title":"Mechanisms of antimicrobial resistance in bacteria","volume":"119","author":"Tenover","year":"2006","journal-title":"Am. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1021\/acs.jctc.8b01039","article-title":"Assessment of GAFF2 and OPLS-AA general force fields in combination with the water models TIP3P, SPCE, and OPC3 for the solvation free energy of druglike organic molecules","volume":"15","author":"Vassetti","year":"2019","journal-title":"J. Chem. Theory Comput."},{"key":"B41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/molecules29030696","article-title":"Temperature-induced restructuring of mycolic acid bilayers modeling the mycobacterium tuberculosis outer membrane: A molecular dynamics study","volume":"29","author":"Vasyankin","year":"2024","journal-title":"Molecules"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1002\/jcc.24467","article-title":"Calculating protein\u2013ligand binding affinities with MMPBSA: Method and error analysis","volume":"37","author":"Wang","year":"2016","journal-title":"J. Comput. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/dkg050","article-title":"The importance of efflux pumps in bacterial antibiotic resistance","volume":"51","author":"Webber","year":"2003","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"B46","unstructured":"Global tuberculosis report: 1.3 drug-resistant TB2023"},{"key":"B47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nature.2017.21550","article-title":"The drug-resistant bacteria that pose the greatest health threats","volume":"543","author":"Willyard","year":"2017","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1021\/acs.jctc.7b00382","article-title":"A continuum poisson\u2013boltzmann model for membrane channel proteins","volume":"13","author":"Xiao","year":"2017","journal-title":"J. Chem. Theory Comput."},{"key":"B49","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2019.01.003","article-title":"Crystal structures of membrane transporter mmpL3, an anti-TB drug target","volume":"176","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12539-015-0263-z","article-title":"Conformational preferences of \u03c0\u2013\u03c0 Stacking between ligand and protein, analysis derived from crystal structure data geometric preference of \u03c0\u2013\u03c0 Interaction","volume":"7","author":"Zhao","year":"2015","journal-title":"Interdiscip. Sciences: Comput. Life Sci."}],"container-title":["Frontiers in Antibiotics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frabi.2024.1362516\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:51:13Z","timestamp":1715143873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frabi.2024.1362516\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":50,"alternative-id":["10.3389\/frabi.2024.1362516"],"URL":"https:\/\/doi.org\/10.3389\/frabi.2024.1362516","relation":{},"ISSN":["2813-2467"],"issn-type":[{"value":"2813-2467","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"article-number":"1362516"}}